These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15261706)

  • 1. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
    Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
    Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
    Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits.
    Ritsner MS; Blumenkrantz H
    Psychiatry Res; 2007 Jan; 149(1-3):59-69. PubMed ID: 17137634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
    Stip E; Caron J; Renaud S; Pampoulova T; Lecomte Y
    Compr Psychiatry; 2003; 44(4):331-40. PubMed ID: 12923712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia.
    Puig O; Penadés R; Gastó C; Catalán R; Torres A; Salamero M
    Psychiatry Res; 2008 Feb; 158(1):11-7. PubMed ID: 18001844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
    Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
    Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
    Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cognitive deficit and schizophrenia].
    Torres A; Méndez L; Olivares JM; Vaamonde A
    Actas Esp Psiquiatr; 2001; 29(1):1-9. PubMed ID: 11333512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting denial function of schizophrenic patients by the picture completion subtest of WAIS-R.
    Rina H; Terao T; Nakano H; Okamoto T; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1185-7. PubMed ID: 15610932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insight, neurocognition and psychopathology in schizophrenia].
    Gil D; Bengochea R; Arrieta M; Alvarez A; Sánchez R; Diego M
    Actas Esp Psiquiatr; 2006; 34(5):317-22. PubMed ID: 16991020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL; Heinrichs RW
    Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attribution biases in schizophrenia: relationship to clinical and functional impairments.
    Cohen AS; Nienow TM; Dinzeo TJ; Docherty NM
    Psychopathology; 2009; 42(1):40-6. PubMed ID: 19023233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.